@CNBC Check $CLRB Few #stocks that Stayed strong since the drop.

Granted EU Patent FDA Grants Fast Track Designation.
FDA supports regulatory approval.
Insiders, CEO &amp; team purchasing shares recently. 
CATALYST -&gt; EST COMP. DATE July 2020
Current price 1.16. First PT $3-4+.Then $6-10+